Literature DB >> 20134469

Angiotensin II and JAK2 put on the pressure.

Kenneth E Bernstein, Sebastien Fuchs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20134469      PMCID： PMC3124240          DOI： 10.1038/nm0210-165

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

Review 1.  Rho GTPases: biochemistry and biology.

Authors:  Aron B Jaffe; Alan Hall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

2.  Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction.

Authors:  K Hirata; A Kikuchi; T Sasaki; S Kuroda; K Kaibuchi; Y Matsuura; H Seki; K Saida; Y Takai
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

3.  Jak2 tyrosine kinase prevents angiotensin II-mediated inositol 1,4,5 trisphosphate receptor degradation.

Authors:  Tiffany A Wallace; Shen-Ling Xia; Peter P Sayeski
Journal:  Vascul Pharmacol       Date:  2005-10-27       Impact factor: 5.773

4.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.

Authors:  M B Marrero; B Schieffer; W G Paxton; L Heerdt; B C Berk; P Delafontaine; K E Bernstein
Journal:  Nature       Date:  1995-05-18       Impact factor: 49.962

Review 5.  Angiotensin II receptors and angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin; P Benfield; D J Carini; R J Lee; R R Wexler; J A Saye; R D Smith
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

6.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.

Authors:  M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

7.  Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system.

Authors:  Midoriko Higashi; Hiroaki Shimokawa; Tsuyoshi Hattori; Junko Hiroki; Yasushi Mukai; Keiko Morikawa; Toshihiro Ichiki; Shosuke Takahashi; Akira Takeshita
Journal:  Circ Res       Date:  2003-09-18       Impact factor: 17.367

8.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

Authors:  Christophe Guilluy; Jérémy Brégeon; Gilles Toumaniantz; Malvyne Rolli-Derkinderen; Kevin Retailleau; Laurent Loufrani; Daniel Henrion; Elizabeth Scalbert; Antoine Bril; Raul M Torres; Stephan Offermanns; Pierre Pacaud; Gervaise Loirand
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440
  8 in total
  4 in total

Review 1.  JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos
Journal:  JAKSTAT       Date:  2012-10-01

2.  Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.

Authors:  Adriana Farias Silva; Marcelo Der Torossian Torres; Leandro Souza Silva; Flavio Lopes Alves; Ana Acácia de Sá Pinheiro; Antonio Miranda; Margareth Lara Capurro; Cesar de la Fuente-Nunez; Vani Xavier Oliveira
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

3.  ROCKing the JAKs.

Authors:  Frank Peelman; Jan Tavernier
Journal:  JAKSTAT       Date:  2013-08-15

4.  Comparative gene expression profile and DNA methylation status in diabetic patients of Kazak and Han people.

Authors:  Cuizhe Wang; Xiaodan Ha; Wei Li; Peng Xu; Zhiwei Zhang; Tingting Wang; Jun Li; Yan Wang; Siyuan Li; Jianxin Xie; Jun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.